| RSS
Business center
Office
Post trade leads
Post
Rank promotion
Ranking
 
You are at: Home » News » International »

Hengrui's Class 1 New Drug Fluzoparib has been Applied for New Clinical Trials

Increase font size  Decrease font size Date:2020-02-04   Views:114

Hengrui has been the hotspot of the medical world recently. According to an announcement of Hengrui Medicine previously, Sun Piaoyang will step down as the chairman of Hengrui, however, he will continue to serve as a director and the chairman of the strategic committee under the Board of Directors of the company; Zhou Yunshu who has served as the general manager for 17 years will serve as the chairman of the new session of the Board of Directors.

The Company, the Board of Directors and its members undertake that the information disclosed does not contain any false statement, misrepresentation or major omission and they are jointly and severally liable for the authenticity, accuracy and integrity thereof.

 
 
[ Search ]  [ ]  [ Email ]  [ Print ]  [ Close ]  [ Top ]

 
Total:0comment(s) [View All]  Related comment

 
Recomment
Popular
 
 
Home | About | Service | copyright | agreement | contact | about | SiteMap | Links | GuestBook | Ads service | 京ICP 68975478-1
Tel:+86-10-68645975           Fax:+86-10-68645973
E-mail:yaoshang68@163.com     QQ:1483838028